0000000000226101

AUTHOR

Anna Maria Ciaccio

showing 27 related works from this author

Vitamin D and Multiple Sclerosis: An Open-Ended Story

2019

Multiple Sclerosis (MS) is a chronic inflammatory autoimmune disease of the Central Nervous System (CNS). Genetic, epigenetic and environmental factors interact together, contributing to the complex pathogenesis of the disease. In the last decades, the role of hypovitaminosis D on MS risk was hypothesised. Several factors drive the regulation of vitamin D status, including genetics. The current review summarises the literature evidence on the association between vitamin D and MS, with a focus on the genetic polymorphisms in vitamin D-related genes. The variants of the genes codifying Vitamin D Receptor (VDR), Vitamin D Binding Protein (VDBP) and CYP enzymes have been investigated, but the f…

0301 basic medicinebusiness.industryMultiple sclerosismedicine.diseaseBioinformaticsGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences030104 developmental biology0302 clinical medicineVitamin D Genetic Genes SNP Multiple sclerosis SusceptibilityVitamin D and neurologyMedicineSNPbusiness030217 neurology & neurosurgery
researchProduct

COVID-19 and Alzheimer’s Disease

2021

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to …

medicine.medical_specialtyNeurological injuryCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)neuroinflammation.DiseaseReviewneuroinflammationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicineIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroinflammation030304 developmental biologyNeurotropic virus0303 health sciencesneurodegenerative niseasebusiness.industrySARS-CoV-2General NeuroscienceHypogeusianervous systembiomarkersADAgeusiabiomarkermedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis

2022

Abstract Objectives Monocyte distribution has recently emerged as a promising biomarker of sepsis, especially in acute setting, such as Emergency Department and Intensive Care Unit. This study aimed to evaluate the accuracy of monocyte distribution width (MDW) for early detecting patients with sepsis by performing a systemic review and meta-analysis of published studies. Methods Relevant publications were identified by a systematic literature search on PubMed and Google Scholar from inception to September 07, 2021. Studies were divided into two groups based on the sepsis criteria applied, namely sepsis-2 or sepsis-3. Results Ten studies including 9,475 individuals, of whom 1,370 with sepsis…

Intensive Care UnitsSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicascreeningSepsisBiochemistry (medical)Clinical Biochemistrymonocyte distribution (MDW)biomarkerHumansGeneral MedicineEmergency Service HospitalBiomarkersMonocytesClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

The role of serum free light chain as biomarker of Myasthenia Gravis

2022

Background and aim: Myasthenia gravis (MG) is a B lymphocyte–mediated disease affecting neuromuscular transmission. The clinical course of MG is unpredictable due to the fluctuating nature and heterogeneity of the disease. Increased levels of free light chains (FLC), which reflect B cell activation, have been detected in different autoimmune disorders. In this study, we evaluated the potential role of FLC as diagnostic and prognostic biomarkers of MG. Materials and methods: 74 MG patients and 52 healthy individuals were included in the study. Serum FLC levels were measured by turbidimetric assay (Freelite, The Binding Site Group Ltd) on the Optilite Analyser System in both groups. In MG pat…

Nephelometry and TurbidimetryBiochemistry (medical)Clinical BiochemistryHumansκFLCImmunoglobulin Light ChainsGeneral MedicineBiomarkerBiochemistryMyasthenia gravisBiomarkersAutoantibodiesFree light chains
researchProduct

A new tool for sepsis screening in the Emergency Department

2021

Abstract Objectives In this study, we developed and evaluated the diagnostic accuracy of the Sepsis Index for early sepsis screening in the Emergency Department (ED). Methods Sepsis Index is based on the combination of monocyte distribution width (MDW) and mean monocyte volume (MMV). Sepsis Index≥1 was selected to define sepsis. We tested its diagnostic accuracy in an ED population stratified in four groups: controls, Systemic Inflammatory Response Syndrome (SIRS), infection, and sepsis, according to Sepsis-2 criteria. Results Patients with sepsis displayed higher median Sepsis Index value than patients without sepsis. At the receiver operating characterictis (ROC) curve analysis for the pr…

medicine.medical_specialtyClinical BiochemistryPopulationDiagnostic accuracyGastroenterologyMonocytesSepsisSepsisInternal medicineHumansMedicineeducationeducation.field_of_studybusiness.industryBiochemistry (medical)Curve analysisArea under the curvemonocyte distribution width (MDW)Emergency DepartmentGeneral MedicineEmergency departmentPrognosismedicine.diseaseSystemic inflammatory response syndromeROC CurveArea Under CurvebiomarkerBiomarker (medicine)mean monocyte volume (MMV)Emergency Service HospitalbusinessBiomarkersClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis

2021

Background: Regulatory T cells (Tregs) alterations have been implicated in the pathogenesis of Multiple Sclerosis (MS). Recently, a crucial role of the X-Linked Forkhead Box P3 (FoxP3) for the development and the stability of Tregs has emerged, and FOXP3 gene polymorphisms have been associated with the susceptibility to autoimmune diseases. The expression of Foxp3 in Tregs is regulated by the transcription factor GATA binding-protein 3 (GATA3) and vitamin D3. The aim of this retrospective case-control study was to investigate the potential association between FOXP3 and GATA3 genetic variants, Vitamin D3, and MS risk. Methods: We analyzed two polymorphisms in the FOXP3 gene (rs3761547 and rs…

VitaminFOXP3chemical and pharmacologic phenomenaSingle-nucleotide polymorphismArticlelcsh:RC321-571Multiple sclerosis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineGeneticPolymorphism (computer science)GATA3Vitamin D and neurologymedicineAlleleVitamin Dlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbusiness.industryGeneral NeuroscienceMultiple sclerosisGATA3FOXP3hemic and immune systemsmedicine.diseasechemistryImmunologybusinessPolymorphisms030217 neurology & neurosurgery
researchProduct

Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.

2022

Abstract Objectives Prostate cancer (PCa) represents the second most common solid cancer in men worldwide. In the last decades, the prostate health index (PHI) emerged as a reliable biomarker for detecting PCa and differentiating between non-aggressive and aggressive forms. However, before introducing it in clinical practice, more evidence is required. Thus, we performed a systematic review and meta-analysis for assessing the diagnostic performance of PHI for PCa and for detecting clinically significant PCa (csPCa). Methods Relevant publications were identified by a systematic literature search on PubMed and Web of Science from inception to January 11, 2022. Results Sixty studies, including…

MalePCaprostate tumordiagnosisscreeningBiopsyBiochemistry (medical)Clinical BiochemistryProstateProstatic NeoplasmsGeneral MedicineProstate-Specific AntigenSettore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinicaclinically significant prostate cancer (csPCa)biomarkerHumansprostate health index (PHI)BiomarkersClinical chemistry and laboratory medicineReferences
researchProduct

Monocyte distribution width (MDW) as a reliable biomarker for urosepsis

2023

Settore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinicabiomarker kidney lithiasis screening sepsisBiochemistry (medical)Clinical BiochemistryGeneral Medicine
researchProduct

Validation of glycated albumin reference interval in healthy Caucasian pregnant women

2022

No abstract available

Settore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaEndocrinologyGylcated albuminPregnancyEndocrinology Diabetes and MetabolismDiabetesInternal MedicineBiomarkerGeneral MedicineActa Diabetologica
researchProduct

The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

2023

Background: TAR DNA-binding protein 43 (TDP-43) aggregation in neuronal cells is recognized as a hallmark of amyotrophic lateral sclerosis (ALS). Although the literature strongly supports the pathogenetic role of TDP-43 in ALS pathogenesis, the role of TDP-43 as a biomarker of ALS is controversial. We performed a systematic review and meta-analysis to assess the diagnostic performance of TDP-43 for ALS. Methods: Relevant publications were identified by a systematic literature search on PubMed and Web of Science from their inception to 8 April 2022. Results: Seven studies, including 472 individuals, of whom 254 had ALS according to the Revised Amyotrophic Lateral Sclerosis Functional Rating …

TDP-43diagnosisClinical BiochemistrybiomarkerALSDiagnostics
researchProduct

Independent Validation of Sepsis Index for Sepsis Screening in the Emergency Department

2021

(1) Background: The early detection of sepsis is still challenging, and there is an urgent need for biomarkers that could identify patients at a high risk of developing it. We recently developed an index, namely the Sepsis Index (SI), based on the combination of two CBC parameters: monocyte distribution width (MDW) and mean monocyte volume (MMV). In this study, we sought to independently validate the performance of SI as a tool for the early detection of patients at a high risk of sepsis in the Emergency Department (ED). (2) Methods: We enrolled all consecutive patients attending the ED with a request of the CBC. MDW and MMV were measured on samples collected in K3-EDTA tubes on the UniCel …

Medicine (General)030213 general clinical medicinemedicine.medical_specialtyClinical BiochemistryEarly detectionDiagnostic accuracy030204 cardiovascular system & hematologyLikelihood ratios in diagnostic testingArticleMonocytesSepsis03 medical and health sciencesR5-9200302 clinical medicineMDWSepsisInternal medicinemedicinebusiness.industryCurve analysisMMVBiomarkerEmergency departmentmedicine.diseasePredictive valueScreeningBiomarker (medicine)businessCBCDiagnostics
researchProduct

Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department

2020

Abstract Objectives The diagnosis of sepsis in the Emergency Department (ED) is challenging and a reliable biomarker is needed. The current study aimed to evaluate the diagnostic accuracy of monocyte distribution width (MDW) for the early identification of sepsis in the ED. Methods We performed a large observational study including consecutive adult patients (≥18 years of age) presenting to the ED between September and November 2019, with an order for complete blood count (CBC) evaluation. A total of 2,215 patients were enrolled and classified based on Sepsis-2 criteria as the control group (1,855), infection group (172), Systemic Inflammatory Response Syndrome (SIRS) group (100), and sepsi…

AdultMalemedicine.medical_specialtyClinical BiochemistryEmergency Department (ED)030204 cardiovascular system & hematologyMonocytesCohort StudiesSepsis03 medical and health sciences0302 clinical medicineSepsisInternal medicinemedicineHumansDistribution (pharmacology)sepsis.Agedmedicine.diagnostic_testbusiness.industryscreeningMonocyteBiochemistry (medical)monocyte distribution width (MDW)Complete blood countGeneral MedicineEmergency departmentMiddle Agedmedicine.diseaseinfectionSystemic inflammatory response syndromemedicine.anatomical_structureROC CurveArea Under Curve030220 oncology & carcinogenesismonocyteBiomarker (medicine)FemaleObservational studyEmergency Service HospitalbusinessBiomarkersClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Comparative analysis of biochip mosaic-based indirect immunofluorescence with enzyme-linked immunosorbent assay for diagnosing myasthenia gravis

2021

Background: The detection of anti-acetylcholine receptor (AChR) and anti-muscle-specific tyrosine kinase (MuSK) antibodies is useful in myasthenia gravis (MG) diagnosis and management. BIOCHIP mosaic-based indirect immunofluorescence is a novel analytical method, which employs the simultaneous detection of anti-AChR and anti-MuSK antibodies in a single miniature incubation field. In this study, we compare, for the first time, the BIOCHIP MG mosaic with conventional enzyme-linked immunosorbent assay (ELISA) in the diagnosis of MG. Methods: A total of 71 patients with MG diagnosis were included in the study. Anti-AChR and anti-MuSK antibodies were measured separately by two different ELISA an…

Medicine (General)ConcordanceClinical BiochemistryAnti-muscle-specific tyrosine kinase antibodiesArticleR5-920DiagnosisMedicineBiochipMyasthenia gravischemistry.chemical_classificationIndirect immunofluorescencebiologybusiness.industryBiomarkermedicine.diseaseMolecular biologyMyasthenia gravismyasthenia gravis; diagnosis; biomarker; anti-acetylcholine receptor antibodies; anti-muscle-specific tyrosine kinase antibodies; BIOCHIPEnzymechemistrybiology.proteinAntibodybusinessBIOCHIPKappaAnti-acetylcholine receptor antibodies
researchProduct

Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study.

2020

Background Monocyte distribution width has been recently proposed as a sepsis biomarker in the emergency department. The aim of this study was to assess the role of monocyte distribution width as a diagnostic biomarker of sepsis in the intensive care unit. Methods In this prospective observational study, we included all consecutive patients admitted to the intensive care unit of the University Hospital “P. Giaccone” of Palermo. Patients were classified into three groups according to Sepsis-3 criteria: (1) patients without sepsis; (2) patients developing sepsis during their hospital stay; (3) patients admitted with sepsis. Monocyte distribution width was measured at admission (groups 1, 2, 3…

Malemedicine.medical_specialtyClinical BiochemistryPilot ProjectsMonocyteslaw.inventionSepsislawSepsisMedicineDistribution (pharmacology)HumansProspective StudiesAgedAged 80 and overbusiness.industryMonocyteGeneral MedicineEmergency departmentMiddle Agedmedicine.diseaseIntensive care unitIntensive Care Unitsmedicine.anatomical_structureEmergency medicineBiomarker (medicine)biomarker sepsis ICU MDW monocytesFemalebusinessBiomarkersAnnals of clinical biochemistry
researchProduct

Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia

2020

Abstract Objective In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy. Methods We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2). Results PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were …

Malemedicine.medical_specialtymedicine.medical_treatmentpediatric.Clinical BiochemistryLipopolysaccharide ReceptorsNeutropeniaAdrenomedullinmr-proADMmalignancieNeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansneutropeniaMedicineBlood cultureProtein PrecursorsFever of unknown originChildFebrile NeutropeniafeverChemotherapymedicine.diagnostic_testReceiver operating characteristicbusiness.industryPresepsinBiochemistry (medical)Age FactorsPrognosismedicine.diseasePeptide FragmentsAdrenomedullinROC CurveoncologicBacteremiaFemalebusinessBiomarkersFebrile neutropeniaLaboratory Medicine
researchProduct

The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis.

2021

Sepsis represents an important global health burden due to its high mortality and morbidity. The rapid detection of sepsis is crucial in order to prevent adverse outcomes and reduce mortality. However, the diagnosis of sepsis is still challenging and many efforts have been made to identify reliable biomarkers. Unfortunately, many investigated biomarkers have several limitations that do not support their introduction in clinical practice, such as moderate diagnostic and prognostic accuracy, long turn-around time, and high-costs. Complete blood count represents instead a precious test that provides a wealth of information on individual health status. It can guide clinicians to early-identify …

lymphocytesMedicine (General)medicine.medical_specialtyAnemiaClinical BiochemistryContext (language use)thrombocytopeniaReviewlymphocyteRBClaw.inventionSepsissepsisR5-920neutrophilslawGlobal healthMedicineIntensive care medicinemedicine.diagnostic_testbusiness.industryComplete blood countneutrophilEmergency departmentCPDmedicine.diseaseIntensive care unitanemiaSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicamonocyteBiomarker (medicine)biomarkersepsibusinessmonocytesCBCDiagnostics (Basel, Switzerland)
researchProduct

Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach.

2023

Monocyte Distribution Width (MDW) is a new generation cell blood count parameter providing a measure of monocyte anisocytosis. In the last decades, it has emerged as a reliable biomarker of sepsis in the acute setting, especially emergency department, and intensive care unit. MDW has several advantages over commonly used sepsis biomarkers, including low-cost, ease and speed of measurement. The clinical usefulness of MDW has been established in several studies and some clinical laboratory medicines have already implemented it in their routine. In this article, we describe the analytical and clinical features of MDW to guide its appropriate use in clinical practice by integrating the research…

MDWSepsisBiochemistry (medical)Clinical BiochemistryGeneral MedicineBiochemistryBiomarkersMonocytesClinica chimica acta; international journal of clinical chemistry
researchProduct

Endothelial Dysfunction and Chronic Inflammation: The Cornerstones of Vascular Alterations in Age-Related Diseases

2022

Vascular diseases of the elderly are a topic of enormous interest in clinical practice, as they have great epidemiological significance and lead to ever-increasing healthcare expenditures. The mechanisms underlying these pathologies have been increasingly characterized over the years. It has emerged that endothelial dysfunction and chronic inflammation play a diriment role among the most relevant pathophysiological mechanisms. As one can easily imagine, various processes occur during aging, and several pathways undergo irreversible alterations that can promote the decline and aberrations that trigger the diseases above. Endothelial dysfunction and aging of circulating and resident cells are…

Inorganic Chemistrycellular senescence chronic inflammation endothelial dysfunction inflamm-ageing vascular alterationsOrganic ChemistryGeneral MedicinePhysical and Theoretical ChemistryMolecular BiologySpectroscopyCatalysisComputer Science ApplicationsInternational Journal of Molecular Sciences
researchProduct

Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting

2021

not available

Oncologymedicine.medical_specialtyClinical BiochemistryMonocytesSepsisLeukocyte CountMDWSepsisInternal medicinemedicineHumansDistribution (pharmacology)Cutoffsepsis.business.industryscreeningMonocyteBiochemistry (medical)Reproducibility of ResultsHematologyGeneral Medicinemedicine.diseasemedicine.anatomical_structurebiomarkerBiomarker (medicine)businessBiomarkersCBCInternational Journal of Laboratory Hematology
researchProduct

Reference interval of monocyte distribution width (MDW) in healthy blood donors.

2020

Abstract Background The aim of the study was to accurately establish the reference interval (RI) of monocyte distribution width (MDW) in healthy blood donors by the direct method using different statistical approaches. Methods MDW was measured in 486 subjects. RI of MDW was calculated by the non-parametric method, the robust method and, the Harrell-Davis bootstrap method and using different tests to identify potential outliers (Dixon-Reed and Tukey). Results Lower and upper reference limits of the RI calculated by the non-parametric method were, 16.22 (90%CI 15.78–16.47) – 23.15 (90%CI 22.80–24.10) (without outlier removal), and 16.44 (90%CI 16.21–16.67) – 22.99 (90%CI 22.33–23.22) (after o…

0301 basic medicine2019-20 coronavirus outbreakSepsiOutlier removalClinical BiochemistryReference rangeBlood DonorsInterval (mathematics)BiochemistryMonocytesReference interval03 medical and health sciences0302 clinical medicineMDWReference ValuesNormal valuesStatisticsHumansMathematicsDirect methodBiochemistry (medical)Direct methodGeneral MedicineReference rangeCalculation methods030104 developmental biologyDistribution (mathematics)Research Design030220 oncology & carcinogenesisOutlierClinica chimica acta; international journal of clinical chemistry
researchProduct

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease

2021

(1) Background: Neurogranin is a post-synaptic protein expressed in the neurons of the hippocampus and cerebral cortex. It has been recently proposed as a promising biomarker of synaptic dysfunction, especially in Alzheimer’s disease (AD). However, more efforts are needed before introducing it in clinical practice, including the definition of its reference interval (RI). The aim of the study was to establish the RI of cerebrospinal fluid (CSF) neurogranin levels in controls and individuals with non-neurodegenerative neurological diseases; (2) We included a total of 136 individuals that were sub-grouped as follows: AD patients (n = 33), patients with non-neurodegenerative neurological …

Medicine (General)diagnosisClinical BiochemistryneurodegenerationbiomarkersRC3; biomarkers; neurodegeneration; controls; diagnosis; prognosis; tauArticlediagnosiR5-920biomarkercontrolsprognosistaucontrolRC3prognosiDiagnostics
researchProduct

Preliminary reference intervals of Glycated Albumin in healthy Caucasian pregnant women

2021

Abstract Background and aims Glycated albumin (GA) could represent a useful biomarker in pregnant women for diagnosing and monitoring gestational diabetes mellitus (GDM). The establishment of reference intervals (RI) is mandatory before assessing its clinical usefulness. The RIs of GA in healthy pregnant women are not well defined. The aim of the current study was to establish the RI in a cohort consisting of Caucasian pregnant women without overt diabetes mellitus or gestational diabetes mellitus. Methods The study included 183 healthy pregnant women. GA was measured on plasma by an enzymatic method (quantILab Glycated Albumin, IL Werfen, Germany). The RI was calculated by the non-parametr…

Glycation End Products Advanced0301 basic medicinemedicine.medical_specialtyClinical BiochemistryPopulationBiochemistry03 medical and health sciences0302 clinical medicineGlycated albuminPregnancyGermanyDiabetes mellitusmedicineHumansGlycated Serum AlbuminWomeneducationSerum AlbuminPregnancyeducation.field_of_studybusiness.industryObstetricsDiabetesBiochemistry (medical)BiomarkerGeneral Medicinemedicine.diseaseGestational diabetesDiabetes GestationalGlucose030104 developmental biology030220 oncology & carcinogenesisCohortBiomarker (medicine)FemalePregnant WomenbusinessBody mass indexClinica Chimica Acta
researchProduct

Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

2021

(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD) antibodies represents a useful tool to estimate the individual protection against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection

0301 basic medicineMedicine (General)Coronavirus disease 2019 (COVID-19)Chemiluminescence immunoassayvirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical BiochemistryAsymptomaticArticleAntibodies03 medical and health sciencesR5-9200302 clinical medicineMedicineKineticMessenger RNAbiologySARS-CoV-2business.industryVaccinationvirus diseasesCOVID-19spikeVaccination030104 developmental biologyAntibody response030220 oncology & carcinogenesisImmunologybiology.proteinmedicine.symptomAntibodybusinessImmunosurvellianceVaccineS-RBD IgGDiagnostics
researchProduct

Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders

2022

(1) Background: Alpha-synuclein (α-syn) is a presynaptic neuronal protein that regulates several neuronal functions. In recent decades, the role of α-syn as a biomarker of neurodegenerative diseases has been explored, especially in synucleinopathies. However, only a few studies have assessed its role as biomarker in other neurological disorders. The aim of the study was to evaluate cerebrospinal fluid (CSF) α-syn levels in several neurological disorders; (2) Methods: We measured CSF α-syn levels by a commercial ELISA kit in 158 patients classified in the following group: controls, Alzheimer’s Disease (AD), cerebrovascular diseases, inflammatory central nervous …

Settore BIO/12 - Biochimica Clinica E Biologia Molecolare Clinicanervous systemparkinson’s diseaseneurodegenerationCSF; biomarker; parkinson’s disease; alzheimer’s disease; neurodegenerationbiomarkerCSFalzheimer’s diseaseGeneral Medicinenervous system diseasesJournal of Clinical Medicine
researchProduct

Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings

2022

Background: Multiple Sclerosis (MS) is a multifactorial disease whose pathogenesis is the result of interaction among genetic, epigenetic, and environmental factors. Among these, a role for vitamin D hypovitaminosis has emerged in recent decades. Vitamin D levels are influenced by both environmental and genetic factors. Single nucleotide polymorphisms (SNPs) in genes codifying for molecules involved in vitamin D metabolism have been associated with an increased risk of developing MS. However, few studies assessed the association of such SNPs with the severity of the disease. The aim of this observational study was to evaluate the potential association among vitamin D status, MS severity, an…

Multiple SclerosisseveritySNPMSVitaminsGeneticsgenetic; prognosis; severity; SNP; MSCholestanetriol 26-MonooxygenaseHumansprognosisgeneticVitamin DCytochrome P450 Family 2Vitamin D3 24-HydroxylaseGenetics (clinical)Genes
researchProduct

Neurogranin as a Novel Biomarker in Alzheimer's Disease

2020

Abstract Background In this study, we investigated the possible role of 2 novel biomarkers of synaptic damage, namely, neurogranin and α-synuclein, in Alzheimer disease (AD). Methods The study was performed in a cohort consisting of patients with AD and those without AD, including individuals with other neurological diseases. Cerebrospinal fluid (CSF) neurogranin and α-synuclein levels were measured by sensitive enzyme-linked immunosorbent assays (ELISAs). Results We found significantly increased levels of CSF neurogranin and α-synuclein in patients with AD than those without AD. Neurogranin was correlated with total tau (tTau) and phosphorylated tau (pTau), as well as with cognitive declin…

MaleOncologymedicine.medical_specialtyClinical BiochemistryDiseaseSensitivity and SpecificityCerebrospinal fluidAlzheimer DiseaseInternal medicineHumansMedicineNeurograninCognitive declineAgedRetrospective StudiesReceiver operating characteristicbusiness.industryBiochemistry (medical)Area under the curveMiddle Agedmedicine.diseaseCSF biomarker neurogranin synapsis synaptic loss α-synucleinalpha-SynucleinBiomarker (medicine)FemaleNeurograninAlzheimer's diseasebusinessBiomarkers
researchProduct

Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine.

2022

AbstractImmunosurveillance by evaluating anti-spike protein receptor-binding domain (S-RBD) antibodies represents a useful tool to estimate the long immunity against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection. The aim of this study was to evaluate the kinetics of antibody response in vaccine recipients. We measured anti-S-RBD IgG levels by indirect chemiluminescence immunoassay on Maglumi 800 (SNIBE, California) in 1013 healthy individuals naïve to SARS-CoV2 infection after two and three COVID-19 vaccine doses. We found that anti-S-RBD IgG levels are higher in females than males. Antibody levels gradually decrease to a steady state after four months since the pea…

MaleVaccinesSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaMultidisciplinaryCOVID-19 VaccinesSARS-CoV-2Immunoglobulin GCOVID-19HumansRNA ViralFemaleAntibodies ViralBNT162 VaccineScientific reports
researchProduct